Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- E. Javier Pretell, MD
Hospital Alberto
Principal Investigator - Hector H. Garcia, MD
Universidad Peruana Cayetano Heredia
Principal Investigator - Javier A. Bustos, MD
Universidad Peruana Cayetano Heredia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Nacional Cayetano Heredia
Lima, Lima Province, Peru
- Hospital Nacional Edgardo Rebagliati
Lima, Lima Province, Peru
- Hospital Nacional Guillermo Almenara
Lima, Lima Province, Peru
- Instituto Nacional de Ciencias Neurologicas
Lima, Peru
- Universidad Peruana Cayetano Heredia
Lima, Peru
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 Dec 2012
- Completion
- 30 Sept 2013
- Last update posted
- 11 Jun 2015
- Registered enrollment
- 156
- Registry id
- NCT00441285
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.